Latest data from the Hong Kong Stock Exchange reveals that on May 28, Norges Bank increased its holdings in TIGERMED (03347) by 825,700 shares. The transaction was executed at a price of HK$30.6386 per share, amounting to a total consideration of approximately HK$25.2983 million. Following this acquisition, Norges Bank's total shareholding in TIGERMED has risen to about 9.2157 million shares, representing a 7.48% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments